These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25878362)

  • 1. Direct Attack on RAS: Intramolecular Communication and Mutation-Specific Effects.
    Marcus K; Mattos C
    Clin Cancer Res; 2015 Apr; 21(8):1810-8. PubMed ID: 25878362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting RAS: The Elusive Prize.
    Bates SE
    Clin Cancer Res; 2015 Apr; 21(8):1796. PubMed ID: 25878359
    [No Abstract]   [Full Text] [Related]  

  • 3. RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?
    Downward J
    Clin Cancer Res; 2015 Apr; 21(8):1802-9. PubMed ID: 25878361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dragging ras back in the ring.
    Stephen AG; Esposito D; Bagni RK; McCormick F
    Cancer Cell; 2014 Mar; 25(3):272-81. PubMed ID: 24651010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Mutant KRAS for Anticancer Therapy.
    Chen F; Alphonse MP; Liu Y; Liu Q
    Curr Top Med Chem; 2019; 19(23):2098-2113. PubMed ID: 31475898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why does the Ras switch "break" by oncogenic mutations?
    Shurki A; Warshel A
    Proteins; 2004 Apr; 55(1):1-10. PubMed ID: 14997535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?
    Cox AD; Der CJ; Philips MR
    Clin Cancer Res; 2015 Apr; 21(8):1819-27. PubMed ID: 25878363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS: A Promising Therapeutic Target for Cancer Treatment.
    Wu HZ; Xiao JQ; Xiao SS; Cheng Y
    Curr Top Med Chem; 2019; 19(23):2081-2097. PubMed ID: 31486755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer: The Ras renaissance.
    Ledford H
    Nature; 2015 Apr; 520(7547):278-80. PubMed ID: 25877186
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving Prospects for Targeting RAS.
    Singh H; Longo DL; Chabner BA
    J Clin Oncol; 2015 Nov; 33(31):3650-9. PubMed ID: 26371146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Discovery by Targeting Mutant KRAS.
    Ye N
    Curr Top Med Chem; 2019; 19(23):2079-2080. PubMed ID: 31762422
    [No Abstract]   [Full Text] [Related]  

  • 12. Oncogenic insertional mutations in the P-loop of Ras are overactive in MAP kinase signaling.
    Klockow B; Ahmadian MR; Block C; Wittinghofer A
    Oncogene; 2000 Nov; 19(47):5367-76. PubMed ID: 11103938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR-based functional profiling of RASopathies and oncogenic RAS mutations.
    Smith MJ; Neel BG; Ikura M
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4574-9. PubMed ID: 23487764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic amino acid substitutions in the inhibitory rap-1A protein cause it to adopt a ras-p21-like conformation as computed using molecular dynamics.
    Chen JM; Brandt-Rauf PW; Pincus MR
    J Biomol Struct Dyn; 1996 Jun; 13(6):925-33. PubMed ID: 8832375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras proteins as therapeutic targets.
    Chakraborty A; Linnane E; Ross S
    Biochem Soc Trans; 2018 Oct; 46(5):1303-1311. PubMed ID: 30154091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and function of p21 ras proteins.
    Shih TY; Hattori S; Clanton DJ; Ulsh LS; Chen ZQ; Lautenberger JA; Papas TS
    Gene Amplif Anal; 1986; 4():53-72. PubMed ID: 3333361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ras oncogene: a novel approach to antineoplastic therapy.
    Scharovsky OG; Rozados VR; Gervasoni SI; Matar P
    J Biomed Sci; 2000; 7(4):292-8. PubMed ID: 10895051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches to Ras signaling modulation and treatment of Ras-dependent disorders: a patent review (2007--present).
    Sacco E; Spinelli M; Vanoni M
    Expert Opin Ther Pat; 2012 Nov; 22(11):1263-87. PubMed ID: 23009088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Ras for cancer treatment: the search continues.
    Baines AT; Xu D; Der CJ
    Future Med Chem; 2011 Oct; 3(14):1787-808. PubMed ID: 22004085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulindac sulfide inhibits Ras signaling.
    Herrmann C; Block C; Geisen C; Haas K; Weber C; Winde G; Möröy T; Müller O
    Oncogene; 1998 Oct; 17(14):1769-76. PubMed ID: 9778042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.